Anthony Alberg to Dehydroepiandrosterone Sulfate
This is a "connection" page, showing publications Anthony Alberg has written about Dehydroepiandrosterone Sulfate.
Connection Strength
0.404
-
Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin. Anticancer Res. 2001 Nov-Dec; 21(6A):4051-4.
Score: 0.192
-
Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev. 2000 May; 9(5):517-21.
Score: 0.173
-
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013 Sep; 14(10):1009-19.
Score: 0.027
-
Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb; 2(1):33-5.
Score: 0.006
-
Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res. 1992 Jan 01; 52(1):1-4.
Score: 0.006